Daratumumab eradicates minimal residual disease in a preclinical model of pediatric T-cell acute lymphoblastic leukemia.
Fotini Vogiatzi, Dorothee Winterberg,Lennart Lenk,Swantje Buchmann,Gunnar Cario,Martin Schrappe,Matthias Peipp,Paulina Richter-Pechanska,Andreas E Kulozik,Jana Lentes,Anke K Bergmann,Thomas Valerius,Fabian-Simon Frielitz,Christian Kellner,Denis M Schewe Blood(2019)
AI 理解论文
溯源树
样例